<info type="SequenceVariant">rs8099917</info> near the <info type="GeneOrGeneProduct">IL28B</info> gene and <info type="SequenceVariant">amino acid substitution</info> at position <info type="SequenceVariant">70</info> in the core region of the <info type="OrganismTaxon">hepatitis C virus</info> (<info type="OrganismTaxon">HCV</info>) are determinants of serum <info type="GeneOrGeneProduct">apolipoprotein B-100</info> concentration in <info type="DiseaseOrPhenotypicFeature">chronic hepatitis C</info>.

The life cycle of the <info type="OrganismTaxon">hepatitis C virus</info> (<info type="OrganismTaxon">HCV</info>) is closely related to host <info type="GeneOrGeneProduct">lipoprotein</info> metabolism. Serum levels of <info type="ChemicalEntity">lipid</info> are associated with the response to <info type="ChemicalEntity">pegylated interferon</info> plus <info type="ChemicalEntity">ribavirin</info> (<info type="ChemicalEntity">PEG-IFN/RBV</info>) therapy, while <info type="SequenceVariant">single nucleotide polymorphisms</info> (<info type="SequenceVariant">SNPs</info>) around the <info type="OrganismTaxon">human</info> <info type="GeneOrGeneProduct">interleukin 28B</info> (<info type="GeneOrGeneProduct">IL28B</info>) gene locus and <info type="SequenceVariant">amino acid substitutions</info> in the core region of the <info type="OrganismTaxon">HCV</info> have been reported to affect the efficacy of <info type="ChemicalEntity">PEG-IFN/RBV</info> therapy in <info type="DiseaseOrPhenotypicFeature">chronic hepatitis</info> with <info type="OrganismTaxon">HCV</info> genotype <info type="SequenceVariant">1b</info> infection. The aim of this study was to elucidate the relationship between serum <info type="GeneOrGeneProduct">lipid</info> and factors that are able to predict the efficacy of <info type="ChemicalEntity">PEG-IFN/RB</info> therapy, with specific focus on <info type="GeneOrGeneProduct">apolipoprotein B-100</info> (<info type="GeneOrGeneProduct">apoB-100</info>) in <info type="SequenceVariant">148</info> subjects with <info type="DiseaseOrPhenotypicFeature">chronic HCV G1b infection</info>. Our results demonstrated that both the <info type="SequenceVariant">aa 70 substitution</info> in the core region of the <info type="OrganismTaxon">HCV</info> and the <info type="SequenceVariant">rs8099917</info> <info type="SequenceVariant">SNP</info> located proximal to the <info type="GeneOrGeneProduct">IL28B</info> were independent factors in determining serum <info type="GeneOrGeneProduct">apoB-100</info> and <info type="GeneOrGeneProduct">low-density lipoprotein</info> (<info type="GeneOrGeneProduct">LDL</info>) cholesterol levels. A significant association was noted between higher levels of <info type="GeneOrGeneProduct">apoB-100</info> (<info type="ChemicalEntity">P</info> = <info type="ChemicalEntity">1.1 10(-3)</info>) and <info type="GeneOrGeneProduct">LDL</info> cholesterol (<info type="ChemicalEntity">P</info> = <info type="ChemicalEntity">0.02</info>) and the subjects having <info type="SequenceVariant">Arg70</info>. A significant association was also observed between subjects carrying the <info type="SequenceVariant">rs8099917</info> <info type="SequenceVariant">TT responder genotype</info> and higher levels of <info type="GeneOrGeneProduct">apoB-100</info> (<info type="ChemicalEntity">P</info> = <info type="ChemicalEntity">6.4 10(-3)</info>) and <info type="GeneOrGeneProduct">LDL</info> cholesterol (<info type="ChemicalEntity">P</info> = <info type="ChemicalEntity">4.2 10(-3)</info>). Our results suggest that <info type="GeneOrGeneProduct">apoB-100</info> and <info type="GeneOrGeneProduct">LDL</info> cholesterol are markers of impaired cellular <info type="GeneOrGeneProduct">lipoprotein</info> pathways and/or host endogenous <info type="GeneOrGeneProduct">interferon</info> response to <info type="OrganismTaxon">HCV</info> in <info type="DiseaseOrPhenotypicFeature">chronic HCV infection</info>. In particular, serum <info type="GeneOrGeneProduct">apoB-100</info> concentration might be an informative marker for judging changes in <info type="OrganismTaxon">HCV</info>-associated intracellular <info type="GeneOrGeneProduct">lipoprotein</info> metabolism in patients carrying the <info type="SequenceVariant">rs8099917</info> <info type="SequenceVariant">responder genotype</info>.